Editas Medicine, Inc. (FRA:8EM)
Germany flag Germany · Delayed Price · Currency is EUR
1.960
+0.190 (10.77%)
At close: Jan 23, 2026

Editas Medicine Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1641017495581,5793,543
Market Cap Growth
67.05%-86.47%34.09%-64.65%-55.43%164.80%
Enterprise Value
41-1183761301,0273,123
Last Close Price
1.661.199.238.4523.5662.60
PS Ratio
4.143.2410.5930.2770.3147.77
PB Ratio
14.260.782.371.653.2411.01
P/TBV Ratio
14.260.782.371.653.2411.01
EV/Sales Ratio
1.04-5.327.0745.7142.10
Debt / Equity Ratio
1.460.260.110.120.050.07
Asset Turnover
0.180.080.150.030.040.17
Quick Ratio
2.813.715.275.8110.677.01
Current Ratio
2.863.755.395.9410.827.20
Return on Equity (ROE)
-211.37%-98.10%-43.17%-48.22%-40.64%-35.36%
Return on Assets (ROA)
-28.26%-35.52%-20.87%-23.70%-19.31%-15.58%
Return on Capital Employed (ROCE)
-85.50%-90.40%-38.80%-49.70%-30.60%-26.20%
Earnings Yield
-104.16%-226.16%-18.52%-36.95%-10.72%-2.68%
FCF Yield
-94.19%-209.00%-16.55%-30.42%-9.56%-4.31%
Buyback Yield / Dilution
-3.57%-8.39%-10.63%-1.55%-15.37%-17.26%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.